Dr Peter Yellowlees comments on research that finally settles the question of whether statin use lowers the incidence of dementia.

Eric Topol asks musician and tech investor D.A. Wallach for his fresh perspectives on revolutionizing the healthcare industry.

Keeping up with the changes to adult immunization schedules can be onerous…unless you have this quick summary of what's new for 2016!

Troubled by news reports of growing violence worldwide, Dr John Marshall asks: What can healthcare providers do to cool feverish minds and heal the body politic?

Eric Topol interviews Donna Spruijt-Metz on how mobile sensors can be used to both understand childhood obesity and change eating behavior.

Drs Harrington and Hernandez discuss the inefficiencies of the US clinical trial system and their involvement in the National Patient-Centered Clinical Research Network's first trial on aspirin dose.

Dr Jacobs discusses a new therapeutic class of agents for migraine prevention and some phase 2 results.

Dr Amy Pollak talks to Dr William Haley of the Mayo Clinic about how to interpret the results from the SPRINT trial and why practitioners should stay tuned for further results.

Are declining PSA screening rates placing men at risk? Dr Chodak discusses the latest opinions for and against routine screening.

Past AACR president Dr Carlos Arteaga describes translational studies and emerging therapies that are transforming the clinical practice of breast cancer.